Article
Author(s):
Top news of the day from across the health care landscape
Individuals with posttraumatic stress disorder (PTSD) and other stress-related psychiatric conditions may be more likely to develop autoimmune diseases than those who don’t suffer from the disorders, Reuters reported. According to the article, researchers studied 106,464 individuals diagnosed with stress disorders, 126,652 of their siblings without stress disorders, and more than 1 million other individuals in Sweden who didn’t have stress disorders. During the study, individuals with PTSD were found to be 46% more likely to develop an autoimmune disorder and more than twice as likely to develop at least 3 autoimmune disorders compared with adults without stress disorders, the article reported.
A new study found that using non-steroidal anti-inflammatory drugs (NSAIDs) around the time of conception significantly increases the risk of miscarriage in the first 8 weeks of pregnancy, Reuters reported. According to the article, researchers compared newly pregnant women who used NSAIDs around the time of conception or early in their pregnancy to those who used acetaminophen or no painkillers. They found that those using NSAIDs around conception carried a more than 4-fold higher risk of early miscarriage, the article reported.
A national shortage of Shingrix, the new shingles vaccine, has prompted retailers to create waiting lists and manufacturers to delay additional promotion, the Washington Post reported. According to the article, CVS began offering the vaccine to patients in March, but because of high demand it became challenging to keep an ample supply at all stores. Shingrix manufacturer GlaxoSmithKline is increasing the US supply available for 2018 and plans to release doses to all customer types on a consistent and predictable schedule for the remainder of the year, the article reported.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa